Inhibition of Renin Angiotensin Axis May Be Associated with Reduced Risk of Developing Venous Thromboembolism in Patients with Atherosclerotic Disease

Abstract

BackgroundArterial and venous thrombosis may share common pathophysiology involving the activation of platelets and inflammatory mediators. A growing body of evidence suggests prothrombotic effect of renin angiotensin system (RAS) including vascular inflammation and platelet activation. We hypothesized that the use of angiotensin converting enzyme inhibitors (ACEIs) or angiotensin receptor blockers (ARBs) plays a role in protecting against venous thromboembolism (VTE) in patients atherosclerosis.MethodsWe conducted a retrospective study, reviewing 1,100 consecutive patients admitted to a teaching hospital with a diagnosis of either myocardial infarction or ischemic stroke from 2005 to 2010. Patients who had been treated with anticoagulation therapy before or after the first visit were excluded. The occurrence of VTE during the follow up period, risk factors for VTE on admission, and the use of ACEIs or ARBs during the follow up period were recorded.ResultsThe mean age of the entire study population was 68.1 years. 52.0% of the patients were female and 76.5% were African American. 67.3% were on RAS inhibitorsThe overall incidence of VTE was 9.7% (n = 107). Among the RAS inhibitor users, the incidence of VTE events was 9.0% (54/603) for the ACEI only users, 7.1% (8/113) for the ARB only users, and 0% (0/24) for the patients taking combination of ACEI and ARB. Among patients on RAS inhibitors, 8.4% (62/740) developed a VTE, compared with 12.5% (45/360) in the nonuser group [HR (hazard ratio), 0.58; 95% CI (confidence interval), 0.39–0.84; P<0.01]. Even after controlling for factors related to VTE (smoking, history of cancer, and immobilization, hormone use) and diabetes, the use of RAS inhibitors was still associated with a significantly lower risk of developing VTE (AHR, 0.59; 95% CI, 0.40–0.88; P = 0.01).ConclusionsThe use of RAS inhibitors appears to be associated with a reduction in the risk of VTE.

Could sodium imbalances predispose to postoperative venous thromboembolism? An analysis of the NSQIP database

“…Medical treatment involves the use spironolactone (aldosterone antagonist or Amiloride) in addition to angiotensin-converting enzyme inhibitors for better control of blood pressure [ 60 ]. Chae et al recently reported that after controlling for factors related to VTE, the use of renin-angiotensin inhibitors was still associated with a significantly lower risk of developing VTE [ 61 ], which may explain why hypernatremic patients in our study receiving steroids were protected against VTE.…”

Red Cell Distribution Width in Relation to Incidence of Stroke and Carotid Atherosclerosis: A Population-Based Cohort Study

“…Activation of the renin–angiotensin system promotes a prothrombotic state, with effects on the development of atherosclerotic thrombosis. [ 15 , 41 ] It also increases erythropoiesis,[ 13 , 42 ] leading to raised RDW. Increased activation of the renin–angiotensin system could be another possible explanation for the association between RDW and stroke.…”

Red Blood Cell Distribution Width: A Novel Predictive Indicator for Cardiovascular and Cerebrovascular Diseases

“…The process also elevates plasma erythropoietin level, causing the rise of RDW level. This probably explains why the RDW levels were higher in patients undergoing stroke [ 115 , 116 ].…”